Metabolic & Weight Research · Research Grade

Tirzepatide — The Dual Agonist

Tirzepatide took the GLP-1 idea and doubled it. It’s a “twincretin” — a dual agonist that hits both the GLP-1 and GIP receptors at once, which is why it became the most-watched metabolic peptide of its generation before retatrutide added a third. Published batch documentation is shown on the COA page when a matching record is available.

Appetite researchBody-weight researchBlood-sugar researchDual-receptor action
Tirzepatide — The Dual Agonist

Why review Tirzepatide with Aeternum Life

Clear intended use

The listing identifies this item as a laboratory research material.

Published specifications

Identity, format, storage, and package information are shown on the product page.

Order-specific delivery

Destination availability, dispatch details, and tracking are confirmed for the order.

Available batch records

COA records appear by product and batch when a matching record is published.

What is Tirzepatide?

Tirzepatide is a synthetic peptide known as a “twincretin” — it activates two incretin receptors at once, GLP-1 and GIP. Where semaglutide pulls one metabolic lever, tirzepatide pulls two, which is the whole reason it drew so much research attention.

Adding the GIP receptor to the GLP-1 pathway is what defines tirzepatide’s research profile — appetite, blood sugar and body weight, studied through two receptors instead of one. It sits between semaglutide (one) and retatrutide (three) in the incretin story. Aeternum Life supplies it as ultra-high-purity research material with a batch-specific Certificate of Analysis on every order.

Research directions

Tirzepatide is a headline name in metabolic research. Here’s what the studies focus on.

Dual-receptor action

The headline: tirzepatide engages GLP-1 and GIP together — the “twincretin” approach that set it apart.

Appetite & food intake

Both incretin receptors are tied to appetite, a central research theme.

Body-weight research

Body weight is the question the whole incretin field is built around.

Blood sugar & insulin

GIP and GLP-1 both influence blood-sugar and insulin signaling.

The GIP contribution

What makes tirzepatide distinct is the GIP arm, studied for what it adds to GLP-1 alone.

Bridge to triple agonists

Its two-receptor design is the step between single (semaglutide) and triple (retatrutide) agonists.

For research purposes only. These materials are not drugs or dietary supplements and are not intended to diagnose, treat, cure or prevent any disease.

Telegram

Join the Aeternum Life community

Get research summaries, batch-record updates, restock alerts, and customer support. We do not provide dosing, reconstitution, or administration guidance.

Join our Telegram

Tirzepatide documentation

  • Published product specification
  • Reported purity and test date when available
  • Batch number shown on matching records
  • Laboratory and verification details only when supplied

The COA page shows the batch documentation currently published. Missing fields are left blank rather than inferred.

Handling & Storage

Guidance for handling Tirzepatide as a laboratory research material.

Storage

Store lyophilized Tirzepatide cold and protected from light, sealed and dry until use.

Laboratory handling

Handle Tirzepatide according to standard laboratory practice for research materials.

Documentation

Published batch documentation is linked when a matching record is available.

Tirzepatide is supplied strictly for laboratory and research use. Not for human or veterinary consumption; no administration or dosing guidance is provided.

Specifications

Name
Tirzepatide
CAS
2023788-19-2
Class
GLP-1 / GIP dual agonist
Appearance
White lyophilized powder
Size
10 mg / 30 mg per vial
Purity
≥ 99% (HPLC, see COA)
Storage
Store at 2–8°C, protect from light

For research use. Not intended to diagnose, treat, cure or prevent any disease.

Frequently asked questions

What is Tirzepatide studied for?

It’s studied in metabolic research around the GLP-1 and GIP pathways — appetite, blood sugar and body weight. We share these as research directions, not medical claims.

How does it compare to semaglutide and retatrutide?

By receptor count: semaglutide one (GLP-1), tirzepatide two (GLP-1 + GIP), retatrutide three (adds glucagon).

Is Tirzepatide for human use?

No. Aeternum Life supplies Tirzepatide strictly as a research-grade material for laboratory research. It is not sold for human or veterinary consumption.

Is a COA available for Tirzepatide?

Published COA records are available by product and batch when a matching record exists. Laboratory and verification details appear only when stated in that record.

About Aeternum Life

Aeternum Life Limited publishes clearly labeled laboratory research materials and accessories, with specifications and available batch documentation.

Learn more about us

Keep up with the Tirzepatide research

New reviews, data and study summaries — sent when there is something worth reading, not on a schedule.

No spam. Unsubscribe anytime.

WhatsApp

Questions before you order?

Message us on WhatsApp for pricing, bulk quotes, stock, shipping and order support — a real person, usually within a few hours.

Message us on WhatsApp

Explore the full Aeternum Life range

Tirzepatide is part of the Aeternum Life research catalog. Review its intended-use status, specifications, and any currently published batch record before ordering.

Browse all products

Product and service note

The current catalog contains laboratory research materials and research accessories. Research materials are not medicines or dietary supplements and are not intended for human or veterinary consumption. Product pages show the intended-use status and the batch documentation currently available.

Dr. AeternumStatus · COA · checkout
Hi 👋 I can help you check a product's research-use status, specifications, available COA records, price, delivery, or checkout. The site's catalog matcher can compare research materials by selected priorities. Results are research-only and not medical advice; I do not provide individualized dosing or administration guidance.